tiletamine hydrochloride has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, T; Hayakawa, M; Kosaka, T; Miyajima, A; Seta, K; Umezawa, K | 1 |
| Chen, CL; Chen, JJ; Chen, PY; Huang, YB; Kao, YC; Sung, PJ; Wen, ZH; Yang, PH | 1 |
2 other study(ies) available for tiletamine hydrochloride and transforming growth factor beta
| Article | Year |
|---|---|
Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction.
Topics: Animals; Apoptosis; Benzamides; Cell Division; Cyclohexanones; Fibrosis; In Situ Nick-End Labeling; Leukocyte Common Antigens; Leukocyte Count; NF-kappa B; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ureter; Ureteral Obstruction | 2003 |
A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF-β Responsiveness by Inhibiting TGF-β Type I Receptor Serine/Threonine Kinase Activity.
Topics: Acetonitriles; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cyclohexanones; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Fluorescent Antibody Technique; Humans; Lung Neoplasms; Phosphorylation; Porifera; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Tumor Cells, Cultured; Tyrosine | 2016 |